Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline

Background: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnosed stage II–IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma. Methods: EMBASE, MEDLINE, and Cochrane Library were investigated for relevant systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirte, Hal, Poon, Raymond, Yao, Xiaomei, May, Taymaa, Ethier, Josee-Lyne, Petz, Lauri, Speakman, Jane, Elit, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774918/
https://www.ncbi.nlm.nih.gov/pubmed/35049696
http://dx.doi.org/10.3390/curroncol29010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774918/
https://www.ncbi.nlm.nih.gov/pubmed/35049696
http://dx.doi.org/10.3390/curroncol29010022

Ejemplares similares